Corporate News 06-Mar-25
Dr Reddys Laboratories allots 11,250 equity shares under ESOS
Dr Reddys Laboratories has allotted 11,250 equity shares under ESOS on 06 March 2025.
Previous News
Dr Reddys Laboratories Ltd slips for fifth straight session
( Hot Pursuit - 02-Jul-25 13:35 )
Dr Reddys Laboratories to hold board meeting
( Corporate News - 24-Jun-25 09:53 )
Dr Reddys Laboratories allots 10,685 equity shares under ESOP
( Corporate News - 23-Jun-25 18:31 )
Dr Reddys Laboratories allots Equity shares
( Corporate News - 16-Jun-25 10:27 )
Dr Reddys Laboratories Ltd up for third consecutive session
( Hot Pursuit - 12-Jun-25 13:05 )
Dr Reddys Laboratories Ltd soars 0.07%, up for fifth straight session
( Hot Pursuit - 09-Jun-25 13:00 )
Dr Reddys Lab gains on global biosimilar deal with Alvotech
( Hot Pursuit - 05-Jun-25 10:10 )
Alvotech and Dr Reddy's enter into collaboration and license agreement for pembrolizumab
( Corporate News - 05-Jun-25 09:20 )
Dr Reddys Laboratories allots 57,840 equity shares under ESOS
( Corporate News - 03-Jun-25 16:28 )
Dr Reddys Labs' manufacturing facility gets two form 483 observations from US FDA
( Hot Pursuit - 26-May-25 09:33 )
DRL’s USA facility gets 2 observations from USFDA
( Hot Pursuit - 19-May-25 08:32 )
Other Stories
LMW schedules board meeting
03-Jul-25 09:15
Julien Agro Infratech announces board meeting date
03-Jul-25 09:15
Alembic Pharmaceuticals announces acquisition of Utility Therapeutics
03-Jul-25 09:15
Shriram Asset Mgt. Company schedules AGM
03-Jul-25 09:14
Ideaforge Technology to convene AGM
03-Jul-25 09:14
D-Link (India) to announce Quarterly Result
03-Jul-25 09:14
Tuni Textile Mills to conduct board meeting
03-Jul-25 09:14
Biocon Biologics receives EU marketing authorisation for Vevzuo® and Evfraxy® biosimilars of Denosumab
03-Jul-25 09:12
Shakti Pumps launches QIP issue
03-Jul-25 09:08
Jai Mata Glass to conduct board meeting
02-Jul-25 19:12
Back
Top
